• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕激素治疗期间子宫内膜癌中镍的细胞化学检测

Cytochemical detection of nickel in endometrial carcinoma during progestogen treatment.

作者信息

Patai K, Szarvas Z, Balogh I

机构信息

2nd Department of Obstetrics and Gynecology, Sommolweis University Medical School, Budapest, Hungary.

出版信息

Acta Chir Hung. 1989;30(3):199-204.

PMID:2596239
Abstract

During progestogen treatment, nickel ions were detected in the human endometrial tissue of patients with endometrial carcinoma by the dimethyloxime cytochemical method. In this paper, the mechanism of action of nickel is dealt with and, because nickel ions have earlier not be detected in human endometrial carcinomatous tissues, the question arises as a result of what kind of cell biological processes, nickel ions appear in the cells of endometrial carcinoma. It is still to be answered whether the progestogen treatment applied can be correlated with the appearance of the trace element in the carcinomatous cell.

摘要

在孕激素治疗期间,采用丁二肟细胞化学方法在子宫内膜癌患者的人子宫内膜组织中检测到了镍离子。本文探讨了镍的作用机制,并且由于此前未在人子宫内膜癌组织中检测到镍离子,因此出现了一个问题,即镍离子是由于何种细胞生物学过程而出现在子宫内膜癌细胞中的。应用的孕激素治疗是否与癌细胞中微量元素的出现有关,这一问题仍有待解答。

相似文献

1
Cytochemical detection of nickel in endometrial carcinoma during progestogen treatment.孕激素治疗期间子宫内膜癌中镍的细胞化学检测
Acta Chir Hung. 1989;30(3):199-204.
2
[Gestagen treatment of endometrial carcinoma].[子宫内膜癌的孕激素治疗]
Zentralbl Gynakol. 1974 Feb 1;96(5):153-7.
3
[Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
Orv Hetil. 1986 Oct 26;127(43):2613-6.
4
[Histological changes observed in the treatment of endometrial glandular epithelioma with lynestrenol].[炔诺孕酮治疗子宫内膜腺上皮瘤的组织学变化]
J Gynecol Obstet Biol Reprod (Paris). 1977 Dec;6(8):1159-69.
5
[Mechanism of action of endocrine therapy of endometrial carcinoma].[子宫内膜癌内分泌治疗的作用机制]
Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-3):1851-7.
6
[Treatment with high doses of progestational agents in endometrial adenocarcinoma].[大剂量孕激素制剂治疗子宫内膜腺癌]
Minerva Ginecol. 1976 Jan;28(1):87-96.
7
[Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation].[通过给予孕激素-雌激素联合制剂对子宫内膜增生和腺癌进行有效的孕激素治疗]
Nihon Gan Chiryo Gakkai Shi. 1988 Oct 20;23(10):2598-605.
8
[Progestational hormones in endometrial carcinoma].[子宫内膜癌中的孕激素]
Ginecol Obstet Mex. 1967 Sep;22(131):1193-203.
9
Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.孕激素疗法与子宫内膜癌传统治疗方法的联合应用。
Bull Schweiz Akad Med Wiss. 1970 Oct;25(4-6):581-5.
10
Oral progestogens and adenocarcinoma of the uterus. An account of 3 cases of advanced endometrial carcinoma treated with an oral progestogen.口服孕激素与子宫腺癌。3例晚期子宫内膜癌口服孕激素治疗病例报告。
J Obstet Gynaecol Br Commonw. 1966 Jun;73(3):487-9. doi: 10.1111/j.1471-0528.1966.tb05194.x.